Immunotherapy trials: current status and future directions with special emphasis on biologic drugs
- PMID: 2425444
- DOI: 10.1007/BF00201907
Immunotherapy trials: current status and future directions with special emphasis on biologic drugs
Similar articles
-
Antibodies in the treatment of lymphoma.Clin Adv Hematol Oncol. 2004 Apr;2(4):210-1. Clin Adv Hematol Oncol. 2004. PMID: 16163182 No abstract available.
-
Immunotherapy of leukemia and lymphoma.Semin Hematol. 1978 Apr;15(2):181-203. Semin Hematol. 1978. PMID: 418506 Review. No abstract available.
-
Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia.Cancer. 1978 Jan;41(1):70-83. doi: 10.1002/1097-0142(197801)41:1<70::aid-cncr2820410112>3.0.co;2-c. Cancer. 1978. PMID: 75055 No abstract available.
-
Future directions in tumor immunotherapy: CTLA4 blockade.Nat Clin Pract Oncol. 2007 Mar;4(3):136-7. doi: 10.1038/ncponc0749. Nat Clin Pract Oncol. 2007. PMID: 17327854 No abstract available.
-
Monoclonal antibodies in cancer therapy.J Clin Oncol. 1983 Sep;1(9):582-90. doi: 10.1200/JCO.1983.1.9.582. J Clin Oncol. 1983. PMID: 6366145 Review.
Cited by
-
Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine.Cancer Immunol Immunother. 1990;32(3):173-8. doi: 10.1007/BF01771453. Cancer Immunol Immunother. 1990. PMID: 2289211 Free PMC article. Clinical Trial.
-
An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells.Clin Exp Metastasis. 1990 Jan-Feb;8(1):89-102. doi: 10.1007/BF00155595. Clin Exp Metastasis. 1990. PMID: 2104578
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical